Home | Science to Startup

Science2Startup^®

S2S is a forum for top scientists from around the world to present their ideas and interact with leading investors and executives in the Boston biotechnology hub.

Mark your calendar!

Submissions received

0

Projects presented

0

VC investors attended

0

Companies funded

0 +

Countries represented

0 +

S2S is an invitation-only symposium featuring the most innovative therapeutics startup ideas from the world’s top research institutions.

featuring biotech ecosystem leaders

by selected Entrepreneurs

opportunities throughout the event

November 2026

Proposal Submissions Due

Academic researchers are invited to submit a one page overview of their therapeutic startup ideas.

December 2026

Semi-Finalists Selected

A subset of the applicants will be invited to submit a short slide deck to support a deeper review by the Advisory Committee.

Late February 2027

Presenters Selected

Selected researchers will be invited to present their work at the S2S Symposium.

March 2027

Mentorship Program Begins

Each Presenter will work with matched advisors to refine their company strategy and presentation.

May 2027

Science2Startup Symposium

A full day event featuring the selected Presenters, topical discussions by industry leaders, and many networking opportunities with the biotech investors and operators in attendance.

S2S participants engage with leading biotech investors.

Jess_Alston_Lifestyle

Partner, F-Prime

Jessica Alston, PhD

Managing Partner, OUP

Matt Cohen, PhD

Deb Palestrant, PhD

Partner & Executive Chair, 4:59 Initiative, 5AM Ventures

Deb Palestrant, PhD

Laura Tadvalkar, PhD

Managing Director, RA Capital Management

Laura Tadvalkar, PhD

Venture Partner, F-Prime

Stacie Weninger, PhD

Jason Rhodes, MBA

Partner, Atlas Venture

Jason Rhodes, MBA

Meet our S2S Class of 2027 Presenters

Presenters will be announced in March 2027!

Jeffrey R. Millman, Ph.D.

Co-founder and CEO IsletForge Innovations

Jeffrey R. Millman, Ph.D.

Christine D. Baker

Co-Founder and CEO Saatient Therapeutics, Inc.

Christine D. Baker, M.B.A

Mandy Pinheiro, Ph.D.

Co-Founder Evina Biosciences

Mandy Pinheiro, Ph.D.

Shawn Iadonato, Ph.D.

CEO CounterX Therapeutics

Shawn Iadonato, Ph.D.

Hunter Newman, Ph.D.

Co-Founder & CEO OsetoCure Therapeutics, Inc.

Hunter Newman, Ph.D.

Stephen Chan, M.D., Ph.D.

Professor and Director Vascular Medicine Institute at the University of Pittsburgh, CSO Amlysion Therapeutics

Stephen Chan, M.D., Ph.D.

Hiroyuki Nakai, M.D., Ph.D.

Founder, President & CEO NeoSakura BTX

Hiroyuki Nakai, M.D., Ph.D.

Jennifer Beecham

COO and Co-Founder Rho Bio

Jennifer Beecham

[gravityform id="39" title="true" ajax="true"]

Science2Startup is generously sponsored by:

Science2Startup is generously sponsored by: